JointHealth™ insight – Summer 2017
It’s summertime: What’s hot in arthritis research?
In this summer issue of JointHealth™ insight, we report on new information presented at the European League Against Rheumatism (EULAR) Annual Congress, which took place in Madrid, Spain, in June 2017. EULAR updates covered include:
- EULAR’s “Don’t Delay, Connect Today” campaign to improve models of care for inflammatory arthritis
- Immunogenicity studies that show comparable results between biosimilars and originator biologics
- Research from Denmark finds no higher patient use of health services after policy transition to biosimilars
- A best practice spotlight on helping patients understand biosimilars
In this issue, you will also find:
- Information about a new Osteoarthritis (OA) Tool for family physicians
- A profile of a young scientist’s research journey looking at osteoarthritis and biomarkers
What’s hot in arthritis research?
In this summer issue of JointHealth™ insight, we report on new information presented at the European League Against Rheumatism (EULAR) Annual Congress, which took place in Madrid, Spain, in June 2017. Approximately 18,000 arthritis researchers, clinicians and patients met in 40°C temperatures to share, discuss and debate the latest in arthritis research. From the Congress, we share with you news of the launch of a EULAR campaign that calls on stakeholders to work together to improve both diagnosis and access to evidence-based treatments.
ACE continues to monitor the important topic of biosimilar research and development to provide our members, subscribers, followers and the arthritis public the latest, unbiased information on this class of medications for inflammatory arthritis. In this edition, you will read the highlights of the ongoing results from the “NOR-SWITCH” and “DANBIO” studies. Complimenting those articles is a close look at the work of the Danish Rheumatism Association. They presented results of a national patient education program on biosimilars in Denmark and ACE had an in depth conversation with the lead author.
But we begin this special issue on current osteoarthritis research with an exciting profile of a budding young scientist who shares his personal journey to discovery in the disease and news about the launch of an Osteoarthritis Tool for family physicians in Canada.